Addus HomeCare Corporation (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Corporation (NASDAQ:ADUS) saw a large decline in short interest during the month of February. As of February 27th, there was short interest totaling 933,071 shares, a decline of 18.8% from the February 12th total of 1,148,513 shares. Approximately 5.3% of the company’s shares are sold short. Based on an average trading volume of 254,326 shares, the short-interest ratio is presently 3.7 days. Based on an average trading volume of 254,326 shares, the short-interest ratio is presently 3.7 days. Approximately 5.3% of the company’s shares are sold short.

Addus HomeCare Trading Up 1.6%

Shares of NASDAQ:ADUS opened at $101.35 on Monday. The firm has a market cap of $1.89 billion, a price-to-earnings ratio of 19.45, a PEG ratio of 1.41 and a beta of 0.92. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $124.43. The company’s fifty day simple moving average is $107.94 and its 200 day simple moving average is $112.08. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.11.

Insider Activity at Addus HomeCare

In other news, EVP Sean Gaffney sold 442 shares of the stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $46,569.12. Following the transaction, the executive vice president owned 20,080 shares of the company’s stock, valued at $2,115,628.80. This represents a 2.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP David W. Tucker sold 379 shares of the firm’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total value of $39,931.44. Following the completion of the transaction, the executive vice president owned 10,423 shares in the company, valued at $1,098,167.28. This represents a 3.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 16,610 shares of company stock worth $1,768,970. 4.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds and other institutional investors have recently bought and sold shares of the company. Royal Bank of Canada lifted its stake in Addus HomeCare by 24.3% in the 1st quarter. Royal Bank of Canada now owns 6,899 shares of the company’s stock valued at $682,000 after acquiring an additional 1,347 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Addus HomeCare by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 10,374 shares of the company’s stock worth $1,026,000 after acquiring an additional 459 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Addus HomeCare by 6.1% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 51,679 shares of the company’s stock valued at $5,111,000 after purchasing an additional 2,952 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of Addus HomeCare by 387.6% in the first quarter. Jane Street Group LLC now owns 11,045 shares of the company’s stock valued at $1,092,000 after purchasing an additional 8,780 shares during the last quarter. Finally, Intech Investment Management LLC lifted its position in shares of Addus HomeCare by 44.7% in the first quarter. Intech Investment Management LLC now owns 14,362 shares of the company’s stock worth $1,420,000 after purchasing an additional 4,439 shares in the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ADUS shares. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Truist Financial set a $135.00 price objective on shares of Addus HomeCare and gave the stock a “buy” rating in a research note on Wednesday, January 7th. Wall Street Zen upgraded shares of Addus HomeCare from a “buy” rating to a “strong-buy” rating in a report on Monday, February 23rd. KeyCorp reaffirmed an “overweight” rating on shares of Addus HomeCare in a research note on Wednesday, February 25th. Finally, Stephens cut their target price on shares of Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $134.33.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.